Free Trial
NASDAQ:MRAI

Marpai (MRAI) Stock Price, News & Analysis

Marpai logo
$1.35 +0.03 (+2.27%)
As of 03:52 PM Eastern

About Marpai Stock (NASDAQ:MRAI)

Key Stats

Today's Range
$1.30
$1.36
50-Day Range
$0.81
$1.35
52-Week Range
$0.40
$2.25
Volume
17,773 shs
Average Volume
19,208 shs
Market Capitalization
$20.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Receive MRAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marpai and its competitors with MarketBeat's FREE daily newsletter.

MRAI Stock News Headlines

MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
MARPAI HIRES DALLAS SCRIP AS CHIEF OPERATING OFFICER
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Market Access RICI Agriculture UCITS (MRAI)
Marpai, Inc. (MRAI) Q4 2024 Earnings Call Transcript
See More Headlines

MRAI Stock Analysis - Frequently Asked Questions

Marpai's stock was trading at $0.95 on January 1st, 2025. Since then, MRAI shares have increased by 42.1% and is now trading at $1.35.
View the best growth stocks for 2025 here
.

Marpai, Inc. (NASDAQ:MRAI) issued its quarterly earnings data on Thursday, May, 9th. The company reported ($0.46) earnings per share for the quarter. The firm had revenue of $7.39 million for the quarter.

Shares of Marpai reverse split on the morning of Thursday, June 29th 2023. The 1-4 reverse split was announced on Thursday, June 29th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 29th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Marpai (MRAI) raised $25 million in an initial public offering on Wednesday, October 27th 2021. The company issued 6,300,000 shares at $4.00 per share. ThinkEquity acted as the underwriter for the IPO.

Shares of MRAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Marpai investors own include NVIDIA (NVDA), Meta Platforms (META), Snowflake (SNOW), iShares Core S&P 500 ETF (IVV), Tesla (TSLA), Airbnb (ABNB) and Allegion (ALLE).

Company Calendar

Last Earnings
5/09/2024
Today
5/14/2025
Next Earnings (Estimated)
5/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
Healthcare
Current Symbol
NASDAQ:MRAI
Fax
N/A
Employees
150
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-28,750,000.00
Pretax Margin
-86.66%

Debt

Sales & Book Value

Annual Sales
$34.87 million
Price / Cash Flow
N/A
Book Value
($1.72) per share
Price / Book
-0.78

Miscellaneous

Free Float
5,605,000
Market Cap
$20.11 million
Optionable
No Data
Beta
4.74
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:MRAI) was last updated on 5/14/2025 by MarketBeat.com Staff
From Our Partners